The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer.
- Citation:
- Cancer vol 110 (2) 363-8
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 81
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA-15083, CA-25224, CA-35101, CA-37404, CA-63848
- Corr. Author:
- Authors:
- Steven E Schild Sumithra J Mandrekar Aminah Jatoi William L McGinnis Phillip J Stella Richard L Deming James R Jett Yolanda I Garces Katie L Allen Alex A Adjei
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-90-24-51, NCCTG-94-24-52
- Phases:
- 3
- Keywords:
- Aged, Aged, 80 and over, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Combined Modality Therapy, Female, Humans, Lung Neoplasms, Male, Radiotherapy, Survival Rate